Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Clinical trial NCT05869201 · COMPLETED

Trial details

NCT number: NCT05869201
Sponsor: St. Petersburg Research Institute of Vaccines and Sera
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Influenza Influenza, Human Influenza Viral Infections Vaccine Reaction Vaccination; Infection

Start date: 2020-10-06
Primary completion: 2020-12-08
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.